University of Crete (UOC)
Investigation of the immune dysregulation in bronchiectasis and identification of novel biomarkers of disease activity and severity and patient-reported outcomes
Abstract
dc:descriptionBackground: Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of immature myeloid cells, which suppress innate and adaptive immune responses in chronic diseases, while regulatory T cells (Tregs) are key immunomodulators maintaining immune tolerance. Plasma fibrinogen and fractional exhaled nitric oxide (FeNO) reflect neutrophilic and eosinophilic airway inflammation, respectively, and are associated with disease activity and severity in different directions in bronchiectasis. Aims: We aimed to characterise the circulating and airway reservoir, functionality, interrelations with effector lymphocytes, and transcriptional profiles of MDSCs and Tregs in bronchiectasis, as well as to concurrently investigate fibrinogen and FeNO and further evaluate the clinical importance of fibrinogen-to-FeNO ratio (FFR) as a composite biomarker in the disease. Materials and Methods: A total of 52 clinically stable patients with cystic fibrosis (CF, six individuals) or non-CF bronchiectasis (46 individuals) and 48 healthy controls were enrolled. Circulating and bronchoalveolar MDSCs, Tregs, and effector lymphocyte subsets (B, helper and cytotoxic T, and natural killer cells) were quantified by flow cytometry. Functional assays were used to assess the T-cell suppression and Treg induction capacity of MDSCs in peripheral blood mononuclear cells. Transcriptome analysis of circulating MDSCs and T cells was conducted. Fibrinogen, FeNO, and the ratio of their normalised values (FFR) were investigated in relation to clinical indicators of disease activity and severity, including respiratory symptoms, inflammatory markers, pulmonary function, radiological extent, airway infection, severity scores, and patient-reported outcomes. Results: Circulating total, polymorphonuclear, and monocytic MDSCs were found expanded (p < 0.001, < 0.0001, and < 0.01, respectively) and functionally enhanced, while circulating Tregs and B cells were found contracted (p < 0.001 and < 0.05, respectively) in patients compared to controls. Pulmonary accumulation of MDSCs and their subpopulations (p < 0.01), but not Tregs, was also observed in patients. The enriched ontology clusters of multiple differentially expressed genes in patients’ MDSCs and T cells reflected altered MDSC-mediated immune response and impaired T-cell proliferation with patterns that resemble respiratory infections and autoimmune diseases. FFR was correlated with both circulating neutrophils (r = 0.36, p < 0.05) and eosinophils (r = −0.39, p < 0.05) and, more strongly compared to fibrinogen and FeNO, with the percentage of predicted forced expiratory volume in the 1st second (r = −0.61, p < 0.001). Interestingly, only FFR was found higher in patients with Pseudomonas aeruginosa isolation in respiratory secretions (p < 0.01). In receiver operating characteristic curves, FFR showed good discriminatory ability to differentiate patients with any level (AUC: 0.80, 95% CI: 0.64–0.96) or severe level (AUC: 0.83, 95% CI: 0.64–1.00) of pulmonary functional impairment and patients with severe disease (AUC: 0.78, 95% CI: 0.62–0.94). Conclusions: Expansion of MDSCs and impaired induction of Tregs characterise bronchiectasis leading to innate–adaptive immune dysregulation, impairing effector responses and immune tolerance. FFR emerges as a candidate biomarker capturing the balance between neutrophilic and eosinophilic inflammation and the net disease activity and severity in bronchiectasis.
Degree
thesis:*- Grantor dc:publisher
- University of Crete (UOC)
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Matthaiou, Andreas
- Ματθαίου, Ανδρέας
Subjects
dc:subject × 36- Φλεγμονή των αεραγωγών
- Βιολογικός δείκτης
- Βρογχεκτασίες
- Κυστική ίνωση
- Ενεργότητα της νόσου
- Σοβαρότητα της νόσου
- Δραστικά λεμφοκύτταρα
- Ινωδογόνο
- Κλασματικό εκπνεόμενο μονοξείδιο του αζώτου
- Ανοσολογική δυσρύθμιση
- Ανοσολογική ανοχή
- Μυελικά κατασταλτικά κύτταρα
- Ρυθμιστικά Τ κύτταρα
- Airway inflammation
- Biomarker
- Bronchiectasis
- Cystic fibrosis
- Disease activity
- Disease severity
- Effector lymphocytes
- Fibrinogen
- Fractional exhaled nitric oxide
- Immune dysregulation
- Immune tolerance
- Myeloid-derived suppressor cells
- Regulatory T cells
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Πνευμονολογία και Αναπνευστικές παθήσεις
- Βασική Ιατρική
- Ανοσολογία
- Clinical Medicine
- Medical and Health Sciences
- Pulmonary and Respiratory Medicine
- Basic Medicine
- Immunology
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/62092